~~<i id='B652CC132D'><strike id='B652CC132D'><tt id='B652CC132D'><pre id='B652CC132D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：fashion 2025-08-28 08:40:21 - browse：9

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Take antibiotics after sex, CDC recommends for certain risk groups

leisure time

explore

focus

hotspot

leisure time

entertainment

AdobeThemomentwhenapersonstopstakingtheirantidepressantisfraught.Notonlycanpatientsseetheirpsychiatr

WSS

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Structure Therapeutics oral GLP

STAT wants to know your pick for a great summer read or listen

Headspace, Meta partner to launch VR meditation app for Quest

An outdated Medicare rule harms dementia patients with anxiety

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

leisure time

hotspot

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

UnitedHealth quietly bought dozens of outpatient centers

Continuity nursing helped my family in our darkest PICU moments

Data don't support strong claims for Covid

23andMe had bad news about my health. I wish a person had delivered it

Former medical device CEO who sold dummy, plastic parts convicted of fraud

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Novo Nordisk obesity pill bests Wegovy in early trial

Guidelines to prevent youth baseball injuries need more muscle

An outdated Medicare rule harms dementia patients with anxiety

explore

Medicare Advantage's lean provider networks lead CMS complaints

A new initiative will help leaders fight the next pandemic

Sen. Paul opposes bill to ban Chinese biotechs

Congress needs to close a vaccine

Headspace, Meta partner to launch VR meditation app for Quest

STAT wants to know your pick for a great summer read or listen

focus

hotspot

leisure time

entertainment